Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nintedanib in Advanced FGFR3-Related Urothelial Carcinoma
NCT02278978Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib in urothelial carcinoma (UC), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
nintedanib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02278978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278978.